The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting brain cells. Read more here.

Sam Altman plans to support a brain computer interface startup to rival Neuralink, as OpenAI expands its AI and technology ...

The Trump administration has ended potential enforcement actions against dozens of tech firms and 165 corporations overall, ...

OpenAI's CEO is reportedly raising funds for a brain implant startup that would directly compete with Elon Musk's Neuralink. He'll have his work cut out for him.

OpenAI CEO Sam Altman is reportedly working to launch a new brain-to-computer interface company, Merge Labs, with early ...

The Austin American-Statesman is seeking an experienced business reporter to cover Elon Musk and his companies, their broad ...

Why Nvidia’s and AMD’s China deal with Trump could backfire. The companies making the most money from the AI boom are the ...

Inner speech — the internal monologue in your brain as you think about what to say — can be decoded by computers and might ...

The OpenAI CEO is planning to back new a brain-implant startup, Merge Labs, according to the Financial Times, citing ...

The feud between Sam Altman and onetime cofounder Elon Musk may soon escalate with OpenAI's reported investment in a ...

OpenAI is reportedly discussing a potential investment in a new startup that aims to compete with Elon Musk’s brain implant ...